“Effectiveness of Casirivimab-Imdevimab and Sotrovimab Monoclonal Antibody Treatment Among High-Risk Patients With Sars-Cov-2 Infection: A Real-World Experience”. 2023. Archives of Clinical and Biomedical Research 7 (3): 325-36. https://fortunejournals.org/ojs/index.php/acbr/article/view/15015.